课题基金 / 基金详情

Cellular and molecular mechanisms of inflammatory T cell regulation.

Cellular and molecular mechanisms of inflammatory T cell regulation.
炎症 T 细胞调节的细胞和分子机制。
批准号:
RGPIN-2015-03665
负责人:
Rangachari, Manu
金额:
$2.33万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Rangachari, Manu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
T cells of the immune system proliferate rapidly in response to bacteria, viruses and tumors. They co-ordinate the body's response to pathogens and cancer by either killing infected cells directly, or by attracting other accessory immune cells to promote inflammation. As T cells can multiply at a dramatic rate in response to infection, and as they produce many antimicrobial and antiviral molecules that can be toxic to the body in large amounts, it is crucial that T cell responses be tightly controlled. T cells thus express negative signaling receptors on their surface. Triggering of negative surface receptors leads to the activation of protein signaling pathways within the T cell, causing them to either die or to reduce their pro-inflammatory functions. In this way, the immune system avoids excessive, inappropriate inflammation once an infection has been cleared.  The main goal of this research program is to identify molecular pathways downstream of negative signaling receptors. We have previously identified a molecule, Bat3, that stops signaling via the negative receptor Tim-3. Bat3 thus promotes T cell-driven inflammation. However, there is much that we still need to learn about the function of Bat3 in T cells. Using a combination of molecular and cell biological approaches, my team and I will define the molecular pathways by which Bat3 operates. We will then identify other T cell proteins that bind to Bat3 and that affect these pathways. We will then use cutting edge technology to determine how specific T cell growth factors can influence the strength of binding of Bat3 to other molecules in living cells. Taken together, this NSERC program will allow us to better understand the molecular signals that mediate negative regulation of T cell responses. The findings will have direct implications for future studies aimed at creating a molecular map of protein interactions that are relevant to maintaining proper function of the immune system. This NSERC program will also ensure the training of future highly qualified students, postdoctoral fellows and research assistants in techniques relevant to fundamental research.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and molecular mechanisms of inflammatory T cell regulation.
  • 批准号:
    RGPIN-2015-03665
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2021
  • 负责人:
    Rangachari, Manu
  • 依托单位:
Cellular and molecular mechanisms of inflammatory T cell regulation.
  • 批准号:
    RGPIN-2015-03665
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2020
  • 负责人:
    Rangachari, Manu
  • 依托单位:
Cellular and molecular mechanisms of inflammatory T cell regulation.
  • 批准号:
    RGPIN-2015-03665
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2019
  • 负责人:
    Rangachari, Manu
  • 依托单位:
Cellular and molecular mechanisms of inflammatory T cell regulation.
  • 批准号:
    RGPIN-2015-03665
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2017
  • 负责人:
    Rangachari, Manu
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: